查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1918191

止鼾器和止鼾手術市場－2026-2031年預測

Anti-Snoring Devices and Snoring Surgery Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計止鼾設備和手術市場將從 2025 年的 18.73 億美元成長到 2031 年的 30.31 億美元，複合年成長率為 8.35%。

止鼾設備和治療方案市場涵蓋了從輕微良性打鼾到阻塞型睡眠呼吸中止症中止症（OSA）等更嚴重疾病的各種習慣性打鼾和睡眠呼吸障礙治療方法。在人們對睡眠品質不佳的健康影響日益關注以及對有效且耐受性良好的治療方法的需求推動下，該市場處於消費者健康產品、牙科睡眠醫學和耳鼻喉科醫學的交叉領域。

核心臨床需求與治療頻譜

這個市場關注的是那些臨床意義常被低估的疾病。打鼾是一種常見症狀，會影響伴侶的睡眠，也可能是潛在阻塞型睡眠呼吸中止症（OSA）的徵兆，而OSA與心血管和代謝風險密切相關。治療方法分為器械治療和手術干預，體現了基於病情嚴重程度、病因和患者意願的階梯式治療模式。器械治療（例如下顎前移裝置（MAD）和舌固定裝置（TRD））是首選的微創治療方案。手術治療的範圍很廣，從微創門診手術到針對特定解剖結構（例如軟顎、扁桃體或舌根）的更複雜的呼吸道重組手術。

主要市場成長促進因素

市場擴張的根本驅動力是全球睡眠呼吸障礙盛行率的不斷上升，而這與人口結構和生活方式的顯著變化密切相關。肥胖率的上升是主要促成因素，因為過重會增加上呼吸道阻塞的風險。同時，人口老化導致風險族群範圍擴大，因為隨著老齡化，上呼吸道肌肉張力會下降。這些相互關聯的趨勢正在不斷擴大目標患者群體。

公眾和臨床醫生對未經治療的睡眠呼吸中止症的健康影響的認知不斷提高，正在改變市場格局。睡眠基金會和專業協會的教育活動已將打鼾和睡眠呼吸中止症定位為一項重要的公共衛生議題。這種認知的提高推動了診斷率的上升，並由此帶來了對治療方案的需求，因為越來越多的人尋求評估和治療，以獲得已證實的健康益處，而不僅僅是將其視為一種社交困擾。

技術和流程的進步一直是醫療器材和外科治療領域發展的關鍵推動因素。在醫療器材領域，創新重點在於透過數位整合（包括用於使用情況追蹤和療效回饋的應用程式）來提高患者的舒適度、個人化治療和治療的連續性。在外科治療領域，微創和組織保留技術正在興起。這些技術包括使用射頻消融術的門診手術、植入（例如腭神經和舌下神經刺激設備）以及先進的雷射和機器人技術，與傳統手術相比，這些技術可以縮短恢復時間並減輕疼痛，使患者更容易接受治療方法。

對個人化和便利治療方案日益成長的需求也在塑造著市場格局。由於無法耐受持續陽壓呼吸器（CPAP），患者擴大尋求替代療法。這推動了對由睡眠牙科專家提供的客製化口腔矯正器以及隱蔽式植入神經刺激設備的需求，後者為中重度睡眠呼吸中止症（OSA）患者提供了一種「佩戴即忘」的解決方案。

市場限制和採用障礙

市場面臨許多挑戰，包括療效不一和難以獲得專業護理。由於打鼾和阻塞性睡眠呼吸中止症的解剖學原因多種多樣，沒有一種設備或療法能夠普遍有效，這可能導致治療方案的反覆試驗和患者滿意度下降。

睡眠呼吸中止症未確診率高是限制因素之一。許多患有症狀明顯且具有臨床意義的阻塞性睡眠呼吸中止症（OSA）的患者並未意識到自身病情，只是將其視為打鼾或疲勞，這限制了可治療的人。此外，手術介入必須解決患者對創傷性、潛在併發症和恢復期的擔憂，即使臨床上確實有必要，這些因素也會阻礙患者接受手術。

區域情勢和趨勢

北美是一個佔據主導地位且成熟的市場。這項優勢源自於該地區肥胖症和睡眠障礙的高發生率、支持睡眠診斷和專科護理的先進醫療基礎設施、較高的患者意識，以及針對診斷性睡眠測試和已通過核准的治療器械（例如，口腔矯正器、舌下神經刺激設備）的完善報銷機制。該地區也是創新中心，匯聚了許多領先的醫療設備和醫療技術公司。

競爭格局與策略重點

競爭格局多元化，涵蓋了專注於睡眠治療的醫療設備製造商、客製化口腔矯正器的牙體技術所網路以及外科技術公司。醫療器材製造商的策略核心在於透過舒適度、療效數據和數位化健康功能來實現產品差異化。主要企業正加大對臨床研究的投資，以擴大其產品的保險覆蓋範圍，並透過直接面對消費者的行銷來提高品牌知名度。

在外科領域，各公司致力於研發和銷售微創系統，為外科醫生提供專業培訓，並收集長期療效數據，以確保該技術符合臨床指南。設備製造商與睡眠診所/牙科診所之間的合作十分普遍，旨在建立整合式醫療服務路徑。

未來市場趨勢

該市場的未來發展方向是更加個人化、與數位醫療整合以及微創解決方案的精細化。家庭睡眠測試和呼吸事件分析人工智慧技術的進步將簡化診斷流程。治療將擴大利用影像學和睡眠研究中的解剖學和生理學數據，以便更好地為每位患者選擇最佳的設備和手術治療方案。

將治療設備與穿戴式睡眠追蹤器結合，實現治療的封閉回路型協調，有望成為新的成長領域。市場參與企業的成功取決於其能否證明，與標準療法相比，其產品在長期療效、治療依從性和生活品質改善方面具有優勢，同時還要應對複雜的醫保報銷環境。隨著睡眠健康被持續認可為整體健康的基礎，醫療需求與生活品質需求的融合將推動止鼾和睡眠呼吸中止症治療市場的持續成長。

本報告的主要優勢：

  • 深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略進入市場的機會。
  • 市場促進因素與未來趨勢：探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
  • 可操作的建議：利用這些見解，在動態環境中製定策略決策，發展新的業務流和收入來源。
  • 受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

以下是一些公司如何使用這份報告的範例

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

  • 2021年至2025年的歷史數據和2026年至2031年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區（包括國家）分類的收入和預測評估
  • 公司概況（策略、產品、財務資訊、關鍵發展等）

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 按設備類型分類的止鼾設備和止鼾手術市場

  • 介紹
  • 口內矯正器
  • 鼻腔裝置
  • 顎骨裝置
  • 舌頭穩定器
  • 其他

6. 依手術方式分類的止鼾器和止鼾手術市場

  • 介紹
  • 射頻消融術
  • 柱狀手術
  • 注射治療打鼾
  • 腭部增高術
  • 其他

7. 按最終用戶分類的止鼾設備和止鼾手術市場

  • 介紹
  • 醫院
  • 診所
  • 其他

8. 各地區止鼾器及止鼾手術市場

  • 介紹
  • 北美洲
    • 依設備類型
    • 透過外科手術
    • 最終用戶
    • 按國家/地區
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依設備類型
    • 透過外科手術
    • 最終用戶
    • 按國家/地區
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 依設備類型
    • 透過外科手術
    • 最終用戶
    • 按國家/地區
      • 英國
      • 德國
      • 法國
      • 西班牙
      • 其他
  • 中東和非洲
    • 依設備類型
    • 透過外科手術
    • 最終用戶
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 依設備類型
    • 透過外科手術
    • 最終用戶
    • 按國家/地區
      • 中國
      • 日本
      • 印度
      • 韓國
      • 台灣
      • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Somnowell Ltd.
  • Inspire Medical Systems, Inc.
  • Zelegent, Inc.
  • GoodSomnia AB
  • Signifier Medical Technologies
  • ResMed Inc.
  • Fisher & Paykel Healthcare Ltd.
  • Apnea Sciences Corporation
  • Philips Respironics

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061616019

Anti-Snoring Devices And Snoring Surgery Market is anticipated to grow at a 8.35% CAGR, growing from USD 1.873 billion in 2025 to USD 3.031 billion in 2031.

The anti-snoring devices and surgery market addresses a spectrum of treatments for habitual snoring and sleep-disordered breathing, ranging from mild, benign snoring to more serious conditions like obstructive sleep apnea (OSA). This market sits at the intersection of consumer health, dental sleep medicine, and otolaryngology, driven by increasing recognition of the health implications of poor sleep and the demand for effective, tolerable interventions.

Core Clinical Need and Treatment Spectrum

The market caters to a condition often underestimated in its clinical significance. Snoring, while common, can be a primary complaint disrupting bed-partner sleep or an indicator of underlying OSA, which carries cardiovascular and metabolic risks. The treatment landscape is bifurcated into device-based therapies and surgical interventions, reflecting a stepped-care approach based on severity, etiology, and patient preference. Device-based solutions, including Mandibular Advancement Devices (MADs) and Tongue Retaining Devices (TRDs), represent a first-line, minimally invasive option. Surgical procedures range from minimally invasive office-based techniques to more complex airway reconstructions, targeting specific anatomical contributors like the soft palate, tonsils, or tongue base.

Primary Market Growth Drivers

Market expansion is fundamentally fueled by the rising global prevalence of sleep-disordered breathing, closely linked to powerful demographic and lifestyle trends. The increasing prevalence of obesity is a paramount driver, as excess weight contributes to upper airway collapsibility. Concurrently, an aging population presents a growing at-risk cohort, as muscle tone in the upper airway diminishes with age. These intertwined trends ensure a continuously expanding addressable patient population.

Heightened public and clinical awareness of the health consequences of untreated sleep apnea is transforming the market. Educational campaigns by sleep foundations and professional societies have moved snoring and sleep apnea higher on the public health agenda. This increased awareness prompts more individuals to seek evaluation and treatment, not merely for social nuisance but for documented health benefits, thereby driving diagnosis rates and subsequent demand for therapeutic solutions.

Technological and procedural advancements are critical catalysts across both device and surgical segments. In the device sector, innovation focuses on improving patient comfort, customizability, and adherence through digital integration, such as apps for usage tracking and efficacy feedback. For surgical treatments, the trend is toward minimally invasive, tissue-sparing techniques. These include office-based procedures using radiofrequency ablation, implants (e.g., palatal and hypoglossal nerve stimulation), and refined laser or robotic techniques that offer reduced recovery time and pain compared to traditional surgery, making intervention more acceptable to patients.

The growing preference for personalized and convenient care also shapes the market. Patients increasingly seek alternatives to Continuous Positive Airway Pressure (CPAP), often citing intolerance to the therapy. This drives demand for custom-fitted oral appliances provided by dental sleep specialists and for discreet, implantable neurostimulation devices that offer a "wear-and-forget" solution for moderate-to-severe OSA.

Market Restraints and Adoption Barriers

The market faces significant challenges related to efficacy variability and access to specialized care. The heterogeneous anatomical causes of snoring and OSA mean no single device or procedure is universally effective, leading to potential trial-and-error in treatment selection and possible patient dissatisfaction.

A major restraint is the substantial rate of undiagnosed sleep apnea. Many individuals with symptomatic, clinically significant OSA remain unaware of their condition, perceiving it merely as snoring or fatigue, which limits the treated population. Furthermore, surgical interventions contend with patient apprehension regarding invasiveness, potential complications, and recovery downtime, which can deter adoption even when clinically indicated.

Geographic Landscape and Regional Dynamics

North America represents a dominant and sophisticated market. This leadership is attributed to a high prevalence of obesity and sleep disorders, advanced healthcare infrastructure supporting sleep diagnostics and specialty care, high patient awareness, and robust reimbursement pathways for both diagnostic sleep studies and approved therapeutic devices (e.g., oral appliances, hypoglossal nerve stimulation). The region is also a hub for innovation, hosting many leading device manufacturers and medical technology companies.

Competitive Landscape and Strategic Focus

The competitive environment is diverse, encompassing medical device companies specializing in sleep therapy, dental laboratory networks for custom oral appliances, and surgical technology firms. For device manufacturers, strategy revolves around product differentiation through comfort, efficacy data, and digital health features. Key players invest in clinical studies to expand insurance coverage for their products and in direct-to-consumer marketing to raise awareness.

In the surgical domain, companies focus on developing and marketing minimally invasive systems, providing specialized training to surgeons, and generating long-term outcome data to establish their techniques within clinical guidelines. Partnerships between device companies and sleep clinics/dental practices are common to create integrated care pathways.

Future Market Trajectory

The future trajectory of this market is oriented toward greater personalization, integration of digital health, and refinement of minimally invasive solutions. Advances in home sleep testing and artificial intelligence for respiratory event analysis will streamline diagnosis. Treatment will increasingly leverage anatomical and physiological data (from imaging and sleep studies) to better match patients with the most appropriate device or surgical target.

The convergence of wearable sleep trackers with therapeutic devices, enabling closed-loop adjustment of therapy, represents a growing frontier. Success for market participants will depend on demonstrating superior long-term outcomes, adherence, and quality-of-life improvements compared to standard therapies, while navigating complex reimbursement landscapes. As sleep health continues to gain recognition as a pillar of overall wellness, the market for anti-snoring and sleep apnea interventions is poised for sustained growth, driven by the convergence of medical necessity and quality-of-life demand.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Anti-Snoring Devices and Snoring Surgery Market Segmentation

  • By Device Type
  • Oral Appliances
  • Nasal Devices
  • Chin Devices
  • Tongue-Stabilizing Devices
  • Others
  • By Surgical Procedure
  • Radiofrequency Ablation
  • Pillar Procedure
  • Injection Snoreplasty
  • Palatal Stiffening
  • Others
  • By End-User
  • Hospitals
  • Clinics
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET BY DEVICE TYPE

  • 5.1. Introduction
  • 5.2. Oral Appliances
  • 5.3. Nasal devices
  • 5.4. Chin Devices
  • 5.5. Tongue-Stabilizing Devices
  • 5.6. Others

6. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET BY SURGICAL PROCEDURE

  • 6.1. Introduction
  • 6.2. Radiofrequency Ablation
  • 6.3. Pillar Procedure
  • 6.4. Injection Snoreplasty
  • 6.5. Palatal Stiffening
  • 6.6. Others

7. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Clinics
  • 7.4. Others

8. ANTI-SNORING DEVICES AND SNORING SURGERY MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Device Type
    • 8.2.2. By Surgical Procedure
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Device Type
    • 8.3.2. By Surgical Procedure
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Device Type
    • 8.4.2. By Surgical Procedure
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Device Type
    • 8.5.2. By Surgical Procedure
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Device Type
    • 8.6.2. By Surgical Procedure
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Somnowell Ltd.
  • 10.2. Inspire Medical Systems, Inc.
  • 10.3. Zelegent, Inc.
  • 10.4. GoodSomnia AB
  • 10.5. Signifier Medical Technologies
  • 10.6. ResMed Inc.
  • 10.7. Fisher & Paykel Healthcare Ltd.
  • 10.8. Apnea Sciences Corporation
  • 10.9. Philips Respironics

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations